Clinical Trial Update: Study of Sunobinop on Craving in Alcohol Use Disorder [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating Sunobinop for cravings in Alcohol Use Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• Sunobinop

Snippet

Sponsor: Imbrium Therapeutics | Conditions: Alcohol Use Disorder | Phase 2 | Status: COMPLETED